Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based studyRafael Cardoso, Marco Weber, Anne Julie Tybjerg et al.|The Lancet Oncology|2021Cited by 477
Trends in incidence of thick, thin and in situ melanoma in EuropeLidia Sacchetto, Stefano Rosso, Roberto Zanetti et al.|European Journal of Cancer|2018Cited by 210
Association Between<i>NRAS</i>and<i>BRAF</i>Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E. Thomas, Kathleen Conway, Sharon N. Edmiston et al.|JAMA Oncology|2015Cited by 192
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Gastone Castellani, Manja Meggendorfer et al.|Blood|2021Cited by 72
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case‐matched studyFortunato Morabito, Massimo Offidani, Sara Galimberti et al.|American Journal of Hematology|2013Cited by 26